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a b s t r a c t
The kidney is a homeostatic organ required for waste excretion and reabsorption of water, salts and
other macromolecules. To this end, a complex series of developmental steps ensures the formation of a
correctly patterned and properly proportioned organ. While previous studies have mainly focused on the
individual signaling pathways, the formation of higher order receptor complexes in lipid rafts is an
equally important aspect. These membrane platforms are characterized by differences in local lipid and
protein compositions. Indeed, the cells in the Xenopus pronephric kidney were positive for the lipid raft
markers ganglioside GM1 and Caveolin-1. To speciﬁcally interfere with lipid raft function in vivo, we
focused on the Sterol Carrier Protein 2 (scp2), a multifunctional protein that is an important player in
remodeling lipid raft composition. In Xenopus, scp2 mRNA was strongly expressed in differentiated
epithelial structures of the pronephric kidney. Knockdown of scp2 did not interfere with the patterning
of the kidney along its proximo-distal axis, but dramatically decreased the size of the kidney, in
particular the proximal tubules. This phenotype was accompanied by a reduction of lipid rafts, but was
independent of the peroxisomal or transcriptional activities of scp2. Finally, disrupting lipid micro-
domains by inhibiting cholesterol synthesis using Mevinolin phenocopied the defects seen in scp2
morphants. Together these data underscore the importance for localized signaling platforms in the
proper formation of the Xenopus kidney.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The kidney is an essential organ required for the excretion of
waste products and the recovery of water, salts and organic
compounds (Smith, 1953; Saxén, 1987; Vize et al., 2003). Three
distinct kidney forms, the pronephros, the mesonephros and the
metanephros are found in vertebrates. They are characterized by
increasing levels of complexity with the pronephros being the
most primitive and only active form in larval stages of aquatic
animals. The metanephros is the adult kidney of higher verte-
brates; the exceptions are birds, ﬁsh and amphibians, which do not
progress past the mesonephric kidney. Importantly, the three
kidney types are evolutionarily interdependent, as the formation
of the pronephros is a prerequisite for the formation of the meso-
and metanephric kidney (Bouchard et al., 2002). Moreover, the
nephron, the functional unit of each kidney form, is very stereo-
typical. It is divided into functionally distinct segments character-
ized by a repertoire of transporters, channels and signaling
molecules (Zhou and Vize, 2004; Raciti et al., 2008) and its
formation is regulated by evolutionarily conserved gene regulatory
networks (Heller and Brandli, 1997; Carroll et al., 1999; Reggiani et
al., 2007; White et al., 2010; Marcotte et al., 2014). Interestingly,
many aspects in kidney development are still poorly understood;
these include the determination of total number of cells present in
the nephron, the regulation of the size of individual cells, but also
cellular speciﬁcation of kidney epithelial cells such as the forma-
tion of the proximal tubular brush border or the contributions of
lipid rafts (Wessely et al., 2013).
Lipid rafts are 10–200 nm small, heterogeneous, highly
dynamic, cholesterol- and sphingolipid-rich domains within the
lipid bilayer (Pike, 2006) and are thought to function by compart-
mentalizing multiple cellular processes (Pike, 2005). In fact, they
potentiate the efﬁciency of growth factor receptor signaling by
local clustering of receptors and downstream signaling compo-
nents. Lipid rafts have been primarily studied in cell culture, where
biochemical approaches elucidated their lipid and protein compo-
sition as well as their impact on cellular function (Simons and
Ikonen, 1997; Pike, 2005; Jacobson et al., 2007). More recently, the
in vivo contributions of lipid rafts have started to emerge. Since
cholesterol is one of the major lipid raft components, removing
cholesterol (using e.g. Methyl-β-cyclodextrin) or inhibiting choles-
terol synthesis (using e.g. Mevinolin) disrupts signaling events
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mediated by lipid rafts (Klein et al., 1995; Taraboulos et al., 1995).
They cause dramatic defects during embryonic development
affecting signaling pathways like sonic hedgehog and Wnt
(Cooper et al., 2003; Tadjuidje and Hollemann, 2006; Anderson
et al., 2011; Reis et al., 2012). Similarly, mice lacking protein
components of lipid rafts such as Caveolin-1 display a wide range
of embryological defects (Drab et al., 2001; Razani et al., 2001;
Zhao et al., 2002).
Another aspect of lipid rafts is that they are very dynamic
structures and their lipid and protein composition must be
constantly adjusted. One of the proteins involved in this process
is the Sterol Carrier Protein 2 (scp2). This multifunctional protein
binds to a subset of lipids such as cholesterol and sphingomyelin
and transports them between cell membranes (Milis et al., 2006;
Filipp and Sattler, 2007). In addition to its role in the cytoplasm,
where it regulates lipid raft composition, scp2 is also present in
peroxisomes, where it contributes to the import of fatty acids and
β-oxidation (Mukherji et al., 2002; Atshaves et al., 2003, 2007a,
2007c). Interestingly, even though scp2 has been knocked out in
mice, its in vivo role in lipid rafts has not yet been investigated
(Seedorf et al., 1998; Fuchs et al., 2001; Atshaves et al., 2007b).
Here we study the connection between scp2, lipid rafts and
kidney development using Xenopus laevis as a model (Wessely and
Tran, 2011). We demonstrate that scp2 mRNA is expressed in the
entire pronephros and that interfering with its function caused a
dramatic reduction in kidney size. Moreover, this effect of scp2
knockdown was a result of interfering with lipid rafts and not due
to its transcriptional or peroxisomal activities because it could be
mimicked by disruption of lipid rafts using the cholesterol synth-
esis inhibitor Mevinolin.
Material and methods
Embryo Manipulations
Xenopus embryos were obtained by in vitro fertilization, main-
tained in 0.1x modiﬁed Barth medium (Sive et al., 2000) and
staged according to Nieuwkoop and Faber (1994). Antisense
morpholino oligomers (MOs) were obtained from GeneTools. The
sequences of the MOs used in this study were 5'–AGC CAT GTT CCA
CAG CAG CAG GTA T-3' (scp2-MO1) and 5'–CCC CAA GGC CAA TAT
TGT GCT GCA G-3' (scp2-MO2). MOs were diluted to a concentra-
tion of 1 mM. To target both scp2 transcripts the two MOs were
mixed at a 1:1 ratio (scp2-MO1þ2). The pCS2-scp(P1)–GFP and
pCS2-scp(P2)–GFP constructs were generated by PCR and sub-
cloned into pCS2-AcGFP (White et al., 2010). For synthetic mRNA
the plasmids were linearized with NotI and transcribed with SP6
RNA polymerase using the mMessage mMachine (Life Technolo-
gies). For all injections a total of 8 nl of morpholino oligomer
solution was injected radially at the 2- to 4-cell stage into Xenopus
embryos. For the GFP reporter assays these injections were
followed by two injections of 2 ng of synthetic mRNA into two
animal blastomeres at the 8-cell stage. Rescue experiments were
performed by injecting embryos with GFP-scp2ΔL DNA into one
blastomere at the 2-cell stage followed by injection of scp2-MO-
1þ2 into all 4 blastomeres at the 4-cell stage. Embryos were
analyzed by 3G8 staining at stage 40 comparing the GFP-scp2ΔL-
injected side to the contralateral side.
To interfere with cholesterol synthesis Xenopus embryos were
cultured until stage 32 and treated with 125 μM Mevinolin
(#M2147, Sigma). Embryos were cultured until sibling controls
reached stage 39/40 and processed for subsequent analyses.
Global metabolic proﬁling was performed by Metabolon, using
six independent sets of uninjected control and scp2-MO1þ2-
injected whole embryos at stage 38.
Whole mount in situ hybridization
The procedure for the in situ hybridizations and the analysis by
paraplast sectioning has been previously described (Belo et al.,
1997; Tran et al., 2007). To generate antisense probes plasmids
were linearized and transcribed as follows: pSK-β1-Na/K-ATPase -
EcoRI/T7 (Tran et al., 2007), pCMV-SPORT6-Basigin - SalI/T7 (Clone
ID: 6631233), pSK-Catalase - EcoRI/T7 (Clone ID: XL156c02), pSK-
Ncc - EcoRI/T7 (Tran et al., 2007), pSK-Nkcc2 - SmaI/T7 (Tran et al.,
2007), pCMV-SPORT6-Nphs1 – EcoRI/T7 (Tran et al., 2007), pSK-
Pmp70 – EcoRI/T7 (Clone ID: XL044i24), pSK–scp2(P1þP2) – EcoRI/
T7 (Clone ID: Xl217c18), pSK-scp2(P1) – XbaI/T7, pCMV-SPORT6-
Sglt1-K – SalI/T7 (Zhou and Vize, 2004).
Histology and immunohistochemistry
For histological staining, dissected mesonephroi were ﬁxed in
Bouin's Fixative, cleared in 70% ethanol, embedded in paraplast,
sectioned at 7 μm, dewaxed, and stained with Hematoxylin and
Eosin. For immunohistochemistry embryos were ﬁxed in Dent's
ﬁxative (Methanol:DMSO¼4:1). For whole mount immunostain-
ing, embryos were incubated overnight with the 3G8 and 4A6
monoclonal antibodies (Vize et al., 1995) followed by incubation
with an anti-mouse Alexa-555 secondary antibody or a Horse-
radish peroxidase-coupled anti-mouse secondary antibody, which
was developed using the ImmPACT DAB kit (Vector Laboratories).
For the analysis of yolk platelet proteins or Caveolin-1 embryos
were ﬁrst processed for 3G8 antibody staining on whole mounts
(using anti-mouse Alexa-555 as secondary antibody). Xenopus
embryos were then embedded in paraplast, sectioned at 25 μm
and probed with antibodies recognizing Vitellogenin (a kind gift of
Dr. M. Kirschner), Caveolin-1 (#610407, BD or #3267, Cell Signal-
ing), Clathrin (#4796, Cell Signaling), Rab5 (#3547, Cell Signaling)
and Rab7 (#9367, Cell Signaling). Primary antibodies were visua-
lized either by staining with anti-rabbit Alexa-647 (in the case of
Vitellogenin) or by anti mouse/rabbit HRP followed by Tyramide
Signal Ampliﬁcation (Perkin Elmer) using Cy5 or Cy3. In some of the
immunostainings, 3G8 was replaced by Erythrina Cristagalli Lectin
(ECL, Vector Laboratories). In contrast to 3G8 immunostaining, which
needs to be performed in whole mounts, ECL also labels proximal
tubules (as initially reported by Dr. P. Vize on Xenbase.org), but is
more versatile. Vitellogenin labeling intensity and number of
Caveolin-1-positive foci were quantiﬁed by the ImageJ software using
only the 3G8- or ECL-positive tubules of 4–5 sections per embryo and
multiple embryos of at least three independent fertilizations for each
condition. Co-localization analyses were performed using the co-
localization module of the Leica Analysis Software (LAS AF). To
determine the overall numbers of cells present in the proximal
tubules, we followed the protocol reported in Romaker et al. (2012).
To visualize the GM1 present in lipid rafts in whole mounts,
embryos were ﬁxed in MEMFA (Sive et al., 2000), incubated with
Horseradish peroxidase-conjugated Cholera Toxin Subunit B (CT-B,
1:1000, #C34780, Invitrogen) and developed using Tyramide Signal
Ampliﬁcation (Perkin Elmer). Cryostat sections were imaged using
FITC-labeled CT-B (1:1000, #C1655, Sigma). Peroxisomal peroxidase
activity was visualized by 3,3'-diaminobenzidine (DAB) staining
following the procedure described by Krysko et al. (2010).
Immunoﬂuorescence analyses of mouse kidneys (embryonic day
E16.5, postnatal day P5 and adult) were performed as described for
the Xenopus embryos. The only differences were that 10 μmparaplast
sections were used. Proximal tubules were visualized using Lotus
Tetragonolobus Agglutinin (LTA, Vector Laboratories), collecting
ducts were counterstained with Dolichos Biﬂorus Agglutinin (DBA,
Vector Laboratories) or an antibody against Carbonic Anhydrase 2
(#SC25596, Santa Cruz Biotechnologies).
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Transmission electron microscopy
Embryos were ﬁxed in 2.5% glutaradehyde/4% paraformalde-
hyde in 0.2 M cacodylate buffer overnight at 4 1C and post-ﬁxed in
1% Osmium Tetroxide for 1 hour at 4 1C. After washing in Maleate
buffer they were incubated in 1% uranyl acetate for 1 hour, washed
again and dehydrated into propylene oxide. Samples were inﬁl-
trated with Eponate and allowed to polymerize for 24 h. Ultra thin
sections of 85 nm were cut with a diamond knife, stained with
uranyl acetate and lead citrate, and then observed with a Philips
CM12 electron microscope operated at 60 kV.
Cell culture Experiments
HEK-293T cells were maintained in Ham's F-12/DMEM supple-
mented with 10% FBS and 1% Pen-Strep (5000 U/ml). GFP-scp2
fusion proteins were generated by PCR by inserting the GFP from
the pAcGFP1-C1 vector into pCS2-pro-scp2, pCS2-scp2 and pCS2-
scp2ΔL. Cells were transfected using Lipofectamine 2000 (Invitro-
gen). Western blot analyses of cell lysates were conducted after
48 h using an anti-GFP antibody (#AB3080, Millipore) and anti-α-
Actin antibody (#A4700, Sigma). Immunoﬂuorescence analyses
were performed using the anti-PMP70 antibody (#P0497, Sigma)
followed by an Alexa-555 coupled anti-rabbit secondary antibody.
Statistical analysis
All experiments were repeated at least three times. In the case
of Xenopus experiments the repetitions used independent fertili-
zations from different females. Data were analyzed by Student's
t-Test.
Results
Lipid Rafts in the pronephric kidney of Xenopus
It has recently been shown that lipid rafts are present during
early Xenopus development (Reis et al., 2012). However, little is
known about their occurrence and function during kidney devel-
opment. In an attempt to address this we performed immuno-
ﬂuorescence analysis on stage 42 Xenopus embryos assaying for
the distribution of the ganglioside GM1, a lipid highly enriched in
lipid rafts (Simons and Ikonen, 1997). We incubated embryos with
the HRP- or FITC-conjugated B subunit of cholera toxin (CT-B),
which speciﬁcally binds to GM1 (Holmgren, 1973; Fishman, 1982).
Embryos were co-labeled with the 3G8 antibody (Vize et al., 1995)
or Erythrina Cristagalli Lectin [ECL, (Romaker et al., 2014)] to
visualize the kidney proximal tubules. Pronephroi were dissected
and imaged as whole mounts using 2-photon microscopy. As
shown in Fig. 1A, CT-B staining was present throughout the kidney
with more abundant signal in the proximal tubules. This was
conﬁrmed using cryostat sections comparing the 3G8-positive
proximal tubules to the structures labeled with the distal tubule
and duct marker 4A6 (Vize et al., 1995) (Fig. 1E-H'). Examining
earlier developmental stages revealed that this enrichment was
present throughout kidney formation but was particularly evident
at stage 42 (Fig. 1C-E'). At the cellular level, CT-B staining was
present throughout the membranes, but was enriched apically
(Fig. 1F,F'). In fact, it may be a result of the formation of the
proximal tubular brush border, which are unusual lipid rafts
specialized to concentrate transporters, enzymes and channels
(Parkin et al., 2001; Danielsen and Hansen, 2003).
As the focus of our study was not on the formation of brush
borders, but on lipid rafts and their involvement in signaling, we
next examined the distribution of Caveolin-1. This structural
protein is concentrated in caveolar lipid rafts, but absent in brush
borders (Parton and Simons, 2007). In contrast to CT-B, Caveolin-1
was present in a punctate pattern throughout the entire kidney
without any obvious proximal-distal speciﬁcity (Fig. 1B, K–N').
Moreover, the pattern could be detected from stage 35 onward
(Fig. 1 I-J'). However, in contrast to the early stages, the increased
brush border-associated CT-B staining at stage 42 (Fig. 1E-F')is not
accompanied by enrichment in Caveolin-1 expression (Fig. 1K-L').
Co-localization studies revealed that Caveolin-1-positive foci
were present at the cell membrane, but were also found intracel-
lularly (Fig. 1 O-P'). It has been reported that Caveolin-1-positive
lipid rafts undergo Clathrin/Rab5-independent endocytosis form-
ing stable transport vesicles that fuse to so-called caveosomes
(Parton and Simons, 2007). To conﬁrm this we performed co-
localization studies with Clathrin, and the two small G-proteins
Rab5 and Rab7 that stain early and late endosomes, respectively.
As shown in Fig.1Q S' each of those endosomal markers show a
speckled appearance similar to Caveolin-1; yet co-localization
analyses did not detect an overlap with Caveolin-1.
One puzzling aspect of the Caveolin-1 pattern in the developing
pronephric kidney was that its distribution is different from the
one described for adult mouse kidneys (Zhuang et al., 2011;
Paunescu et al., 2013). Instead of a punctate expression, these
studies did not detect any Caveolin-1 staining in proximal tubules,
but a basolateral enrichment in collecting ducts. As an identical
Caveolin-1 pattern in the Xenopus pronephros was observed with
two different antibodies (compare Fig. 1O,O' and Supplementary
Fig. S1A,A'), we reasoned that this reﬂected differences between
lipid rafts during kidney development and adult kidney home-
ostasis. To conﬁrm this, we examined Caveolin-1 staining in
developing (i.e. embryonic day E16.5 and postnatal day P5) and
adults mouse kidneys. Indeed, proximal tubules displayed a
punctate staining pattern at E16.5, but lost this expression by P5
(Supplementary Fig. S2A–H and data not shown). Conversely,
collecting ducts initially exhibited rather sparse Caveolin-1 stain-
ing, but acquired strong, baso-laterally enriched staining (Supple-
mentary Fig. S2I–P). Finally, as in Xenopus, the Caveolin-1-positive
foci in E16.5 mouse proximal tubules did not co-stain with
markers of the endosomal compartment (Supplementary Fig. S3).
Together, these experiments suggest that the cells of the
pronephros contain Caveolin-1-positive rafts, which seem to be
actively recycling during kidney development.
Identiﬁcation and characterization of Xenopus Scp2
We next wanted to address the functional relevance of lipid
rafts in pronephros development. While depleting cholesterol or
interfering with its biosynthesis is a well-established method to
study lipid rafts (Hooper, 1999), we instead decided to focus on
Sterol Carrier Protein 2 (scp2), a multifunctional protein (Fig. 2A)
that is known to be involved in the remodeling of the lipid
composition of rafts (Gallegos et al., 2001; Wirtz, 2006).
Identiﬁcation and characterization of the Xenopus homolog
demonstrated that Xenopus scp2 is an evolutionarily conserved
protein that is localized to the cytoplasm and peroxisomes
(Supplementary Figs. S4 and S5). Most importantly, it was
expressed in the pronephric kidney. Whole mount in situ hybridi-
zation analyses detected full-length scp2 mRNA [scp2(P1þP2)]
maternally in the animal region (Fig. 2B,C); zygotic expression was
rather low and uniform until tailbud stages, when staining in the
hatching gland and pronephros were ﬁrst detected (Fig. 2D). At
stage 35, additional expression domains in the head, branchial
arches, optic and otic vesicles, neural tube, notochord and somites
appeared (Fig. 2E and data not shown). At stage 45, scp2 mRNA
was found in all endodermal organs and the pronephros, but
little expression was now detected in neural and muscle tissue
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Fig. 1. Lipid Rafts in the Pronephric Kidney. (A,B) Whole mount immunostaining of Xenopus pronephroi using the B-subunit of Cholera Toxin (CT-B) or an antibody against
Caveolin-1 at stage 42. Proximal tubules were counterstained using the 3G8 antibody (A) or ECL (B). pt, proximal tubules; dt, distal tubules. (C–H') Cryostat sections of stage
35, 39 and 42 Xenopus embryos stained with CT-B and either 3G8 (C–F') or 4A6 (G–H'). (I–N') Paraplast sections of stage 35, 39 and 42 Xenopus embryos stained with
Caveolin-1 and 3G8 (I–L') or 4A6 antibodies (M–N'). The gray-scale panels show CT–B and Caveolin-1 staining only, while the color panels show the merged images. (O–S')
Paraplast sections of stage 40 Xenopus embryos stained with anti-Caveolin-1 in combination with ECL (O–P'), Clathrin (Q,Q'), Rab5 (R,R') and Rab7 (S,S'). In panel P and P' co-
localization of Caveolin-1 and ECL staining in the apical domain was analyzed using the co-localization module of the LAS AF software and is indicated by white pixels. The
panels F,F',H,H',L,L',N,N',O',P',Q',R' and S' are close-ups of the areas indicated by the white boxes.
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(Fig. 2I,I'). Finally, the kidney expression of scp2 was not only
restricted to the pronephric kidney, but could also be observed in
the mesonephros of adolescent Xenopus (Fig. 2K,L).
In designing a knockdown strategy for scp2 using antisense
morpholino oligomers (MOs) we needed to consider its unusual
genomic organization. In humans, SCP2 protein is encoded by two
transcripts, SCPX and PRO-SCP2 (Ohba et al., 1994, 1995;
Ferdinandusse et al., 2006; Atshaves et al., 2007b). Indeed, a
similar genomic organization was identiﬁed in Xenopus laevis
and Xenopus tropicalis (Supplementary Fig. S4 and data not
shown). To prove that both transcripts are indeed present in
Xenopus, we ﬁrst performed in silico analyses examining the
Xenopus scp2 EST sequences available in the public databases.
The comparison revealed three classes, clones sequenced from the
3' end, clones sequenced from the 5' end that correspond to the
full-length transcript and ﬁnally clones sequenced from the 5' end
that mapped to about 1100 nucleotides downstream (Supplemen-
tary Fig. S6). This class is in agreement with a transcript initiated
Fig. 2. Expression of Scp2 mRNA during Xenopus Development. (A) Scheme depicting the multiple described activities of scp2 protein. (B) Schematic of the two different
antisense probes used. (C–H) Whole mount in situ hybridization of 4-cell stage, stage 28 and stage 35 embryos using the scp2(P1þP2) or the scp2(P1) probe. Inset in (D) and
(G) shows a frontal view highlighting the hatching gland expression. (I–J') In situ hybridization on paraplast sections of stage 45 embryos using both scp2 mRNA probes.
Panels (I') and (J') show close-ups of the pronephric kidney area. no, notochord; nt, neural tube; so, somites; pn, pronephros; en, endoderm. (K–M) Hematoxylin and Eosin
(H&E) staining (K) and in situ hybridization on paraplast sections using scp2(P1þP2) or scp2(P1) RNA probes (L,M) of an adolescent Xenopus mesonephros.
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from an alternative promoter similar to the pro- scp2 transcript in
humans.
Next, we examined whether the two transcripts differed in
their expression patterns by in situ hybridizations. The initial
antisense probe [scp2(P1þP2)] corresponded to the entire mRNA
and recognized transcripts from both promoters (Fig. 2B). A probe
encompassing only the sequence found in the longer transcript,
scp2(P1), detected the same expression domains as scp2(P1þP2)
(Fig. 2F-H, J,J' and M). Unfortunately, the reverse experiment
visualizing only the short transcript was impossible due to the
extensive sequence overlap. However, the fact that the staining
using the scp2(P1) probe was generally much weaker than the scp2
(P1þP2) suggested that both transcripts were present in the
pronephros. This interpretation could also be conﬁrmed by RT-
PCR analyses using transcript-speciﬁc primers (data not shown).
Based on these data, we conclude that Xenopus scp2 is tran-
scribed from two promoters and is expressed in the pronephric
kidney.
Knockdown of scp2 interferes with proximal tubule development
With both promoters active in early kidney development, we
designed two antisense morpholino oligomers (MOs) to block
translation of both transcripts (scp2-MO1 and scp2-MO2) (Fig. 3A).
The efﬁcacy of both MOs were tested using GFP-fusion protein
constructs containing the respective MO binding sites [scp2(P1)–
GFP and scp2(P2)–GFP]. In contrast to uninjected controls, Xenopus
embryos injected at the 8-cell stage with 2 ng of either scp2(P1)–GFP
or scp2(P2)–GFP mRNA displayed green ﬂuorescence at the gastrula
stage (Fig. 3B,C,E); this expression was lost when the embryos were
co-injected at the 2- to 4-cell stage with either 3.2 pmol scp2-MO1 or
scp2-MO2 (Fig. 3D,F).
Next, we tested whether loss-of-scp2 affected pronephric
development. To this end, Xenopus embryos were injected at the
2- to 4-cell stage with 3.2 pmol scp2-MO1, 3.2 pmol scp2-MO2 or a
mixture of both MOs (each at a concentration of 3.2 pmol; scp2-
MO1þ2), cultured until stage 40 and processed for 3G8/4A6
immunohistochemistry. Embryos lacking scp2 showed a dramatic
reduction of the 3G8-positive area and a drastic loss of 4A6
staining (Fig. 3G-N,S and Supplementary Fig. S7A). Since both
3G8 and 4A6 label terminally differentiating renal epithelial cells,
we also performed whole mount in situ hybridization using a
range of pronephric marker genes. These, however, did not show
defects in overall kidney formation (β1-Na/K-ATPase, Fig. 3O-R) or
proximal-distal patterning (Nphs1, Sglt1K, Nkcc2, Ncc, Supplemen-
tary Fig. S7B–E'). The phenotypes were observed in the injections
of the individual MOs (with scp2-MO1 being more effective than
scp2-MO2), but were more pronounced upon co-injection of both
MOs (Fig. 3G-N,S and Supplementary Fig. S7A). The cooperativity
supported our interpretation that the scp2-MOs had a gene-
speciﬁc phenotype. Importantly, injection of a standard control
MO did not result in any of these defects [data not shown and
(Tran et al., 2007; Agrawal et al., 2009)]. We also performed rescue
experiments of the scp2 knockdown phenotype by co-injection of
constructs resistant to scp2-MO1þ2 activity. Unfortunately, scp2
mRNA injected embryos did not survive past gastrula stage due to
dissociation of epithelial cell layers followed by apoptosis (data not
shown). To circumvent this early lethality, we injected embryos
with plasmid DNA instead. Even though this still impaired survi-
val, a percentage of embryos survived until stage 40. Most
importantly, those embryos exhibited a partially restored size of
the 3G8-positive proximal tubule (Fig. 3T-V).
Next, we decided to more accurately assess the size of the
proximal tubules in the absence of scp2. To this end, we followed
the approach described in Romaker et al. (2012) and quantiﬁed
the total number of cells present in the proximal tubules.
Uninjected control embryos increased their proximal tubules from
approximately 50 cells at stage 34 to about 230 cells at stage 40,
and 320 cells at stage 42 (Fig. 3W) (Romaker et al., 2014). However,
scp2 morphants showed little growth and the proximal tubules
consisted in average of 110 cells both at stage 40 and 42. This
reduction of proximal tubular size caused by scp2 knockdown was
very reminiscent of a recent study on G-protein αs function in the
pronephric kidney (Zhang et al., 2013). There we demonstrated
that the defect in proximal tubule size was accompanied by an
impairment of yolk degradation that normally occurs during
embryonic development. The same was observed in scp2 mor-
phants. Transmission electron microscopy revealed more electron-
dense yolk platelets in the proximal tubules of scp2-MO1þ
2-injected embryos compared to uninjected control embryos
(Fig. 3Y,Y'). This was conﬁrmed by immunoﬂuorescence using an
antibody against the major yolk protein, vitellogenin (Jorgensen et
al., 2009) (Fig. 3X,Z,Z').
Together, these data show that loss-of-scp2 interferes with the
formation of a correctly proportioned pronephric kidney by impair-
ing the proximal tubular growth and yolk platelet degradation.
Scp2 and lipid rafts
Scp2 is involved in the regulation of lipid raft composition in a
variety of cell lines (Zhou et al., 2004; Atshaves et al., 2007a). To
directly evaluate if the loss-of-scp2 causes a defect in lipid rafts
in vivo, we performed immunoﬂuorescence analysis for lipid rafts
using the two different Caveolin-1 antibodies. Scp2-MO1þ2-
injected embryos displayed a reduction in the number and
intensity of Caveolin-1-positive foci in the proximal tubules
(labeled with ECL) when compared to uninjected controls
(Fig. 4A-B' and Supplementary Fig. S1A–B'). Quantiﬁcation of
several independent embryos from multiple experiments demon-
strated that this effect was statistically signiﬁcant (Fig. 4E). More-
over, other domains with scp2 expression such as the distal
pronephric tubules, neural tube and notochord exhibited a
reduced number of Caveolin-1-positive foci in the scp2 morphants
(Supplementary Fig. S8).
Scp2 has been implicated in the function of lipid rafts, but not
in the regulation of other endocytic pathways (Atshaves et al.,
2003; Zhou et al., 2004). To validate the speciﬁcity of the defect,
we performed immunoﬂuorescence analysis for Rab5 and Clathrin
comparing the proximal tubules of uninjected controls and scp2-
MO1þ2-injected embryos. Indeed, no signiﬁcant changes in the
staining patterns could be detected (Fig. 4C-D' and Supplementary
Fig. S1C–D').
Mechanistically, scp2 transports cholesterol and other lipids
between different membrane compartments, but has rather little
effect on overall cholesterol levels (Seedorf et al., 1998). In an
attempt to validate this in vivo, we performed a metabolomics
analysis comparing uninjected and scp2-MO1þ2-injected whole
Xenopus embryos at stage 38. As shown in Fig. 4F, the levels of
neither cholesterol, nor its metabolic precursor, 7-dehydrocholes-
terol, were signiﬁcantly different between the two conditions.
Furthermore, palmitoyl sphingomyelin, another lipid bound by
scp2 and enriched in lipid rafts (Atshaves et al., 2007a), was not
altered as well.
Based on these data we conclude that loss-of-scp2 causes a
decrease in Caveolin-1-positive lipid rafts, which in turn could be
responsible for the reduction in proximal tubule size.
Non-raft Functions of Scp2
To further substantiate this interpretation, we next examined
whether the non-raft functions of scp2 (Fig. 2A) contribute to the
proximal tubular phenotype. Scp2 has been implicated in gene
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transcription by acting as a positive co-factor for the expression of
Basigin (also known as CD147) in a glioblastoma cell line (Ko and
Puglielli, 2007). While the Xenopus homolog of Basigin was
strongly expressed in the pronephric kidney from stage 28
onwards (Supplementary Fig. S9), its expression levels were not
downregulated upon microinjection of scp2-MO1þ2 (Supplemen-
tary Fig. S7I,I').
Finally, scp2 is also found in peroxisomes. Here, it functions as a
fatty acyl-CoA carrier and solubilizing protein that facilitates the
degradation of long and branched fatty acids (Seedorf et al., 1998;
Mukherji et al., 2002). Thus, we performed two functional analyses
to identify, whether scp2 morphants exhibit peroxisomal defects.
To visualize peroxisomal catalase activity, embryos were stained
with 3,3'-diaminobenzidine (DAB) (Fahimi and Baumgart, 1999;
Krysko et al., 2010). But no obvious differences could be detected
between uninjected controls and scp2-MO1þ2-injected embryos
(Supplementary Fig. S7F,F'). Secondly, as peroxisomes are an
important organelle in fatty acid degradation, we surveyed our
metabolomics data for changes in fatty acid levels. Indeed, several
long chain fatty acids were signiﬁcantly reduced in embryos
lacking scp2, while medium chain fatty acids, which are primarily
degraded in the mitochondria (Wanders, 2004), did not show such
changes (Supplementary Table S1). In line with these assays whole
mount in situ hybridization for Catalase did not show changes,
while the peroxisomal fatty acid transporter, Pmp70, was greatly
reduced (Supplementary Fig. S7G–H'). However, this effect was not
only observed in the pronephros, but throughout the entire
embryo.
Fig. 3. Phenotype of Xenopus Embryos Lacking Scp2. (A) Sequence alignment of the two scp2 pseudo-alleles in the regions targeted by either scp2-MO1 or scp2-MO2. The
position of the MOs and the start codons (P1 and P2) are indicated. Non-conserved nucleotides are highlighted in red. (B–F) Xenopus embryos were injected animally with
the scp2-MO1 and scp2-MO2 at the 2-4 cell stage followed by two diametral injections of synthetic mRNA encoding either scp2(P1)–GFP or scp2(P2)–GFP at the 8-cell stage,
while control embryos were only injected with the scp2(P1)–GFP or scp2(P2)–GFP mRNA. Embryos were analyzed at stage 10.5 by ﬂorescence microscopy. Representative
images are shown and the percentage of GFP-positive embryos is indicated in the upper right corner of each panel. (G-R) 3G8 or 4A6 immunostaining at stage 40 (G–N) or
β1-Na/K-ATPase whole mount in situ hybridization at stage 39 (O-R) of Xenopus embryos injected with scp2-MO1, scp2-MO2 or a combination of both MOs (scp2-MO1þ2).
(S) Quantiﬁcation of the 3G8 whole mount immunostaining. The embryos were categorized in three groups representing increasing severity of the phenotype. The amount of
MOs injected and the number of embryos analyzed is indicated. (T–V) 3G8 immunostaining of stage 40 controls or embryos injected with scp2-MO1þ2 in the presence or
absence of GFP-scp2ΔL DNA. Panels show representative images of four independent experiments. (W) Bar diagram of the number of proximal tubular cells in embryos
injected on one side with scp2-MO1þ2 and comparing the injected and uninjected side at stages 40 and 42. The number of embryos analyzed is indicated in the individual
bars. Data were analyzed by paired Student0s t-Test; the three asterisks indicate a signiﬁcance of po0.001. (X) Bar diagram of the measured intensity of the vitellogenin
immunostainings (see panel Z, Z'). Data were analyzed by Student's t-Test and asterisk represent a signiﬁcance of po0.05. (Y–Z') Uninjected and scp2-MO1þ2-injected
embryos at stage 40 were analyzed by transmission electron microscopy (Y,Y') or immunoﬂuorescence staining of proximal tubules using 3G8 (red) and anti-vitellogenin
antibodies (green) (Z,Z'). Nuclei were counterstained with DAPI. Red arrowheads in (Y,Y') indicate individual electron-dense yolk platelets.
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Together these data demonstrate that scp2 morphants also
show changes in peroxisomal-mediated fatty acid degradation, but
not in transcriptional regulation of Basigin.
Reduction in lipid rafts causes reduced proximal tubule size
The data so far do not conﬁrm that the lipid raft defects are
causative for the decrease in proximal tubular size. Thus, we
decided to address this question by interfering with lipid raft
function using Mevinolin, an inhibitor of HMG-CoA reductase, the
rate-limiting enzyme in cholesterol biosynthesis (Taraboulos et al.,
1995). To assess whether the phenotype resembles the one of scp2
morphants, embryos were treated with 125 μM Mevinolin from
stage 32 onwards and analyzed at late tailbud stages. As expected,
Caveolin-1 immunoﬂuorescence analysis demonstrated that the
number of lipid rafts in proximal tubules labeled with ECL was
greatly reduced (Fig. 5A-C). Importantly, Mevinolin-treated
embryos - like the scp2-MO1þ2-injected counterparts - displayed
reduced proximal tubular size as measured by 3G8 immunostain-
ing followed by cell counting (Fig. 5D-E'). They also showed
reduced intensity of 4A6 staining in the pronephric duct, yet this
effect was less prominent than in scp2-MO1þ2-injected embryos
(Fig. 5F,F'). Additionally, Mevinolin-treated embryos exhibited ectopic
4A6 staining in the proximal tubular area (indicated by red arrow-
heads in Fig. 5F'). This phenotype was occasionally observed in scp2
morphants (data not shown), but was a hallmark of embryos with
hyperactivated G-protein αs function (Zhang et al., 2013). Finally, - like
in the case of scp2 morphants - the kidney phenotype in Mevinolin-
treated embryos was restricted to later events in pronephros devel-
opment. Whole mount in situ hybridizations using β1-Na/K-ATPase
and a panel of segment-speciﬁc marker genes showed changes in the
architecture but not patterning of the kidney between control and
Mevinolin-treated embryos (Fig. 5G,G' and Supplementary Fig. S10).
Importantly, the Mevinolin experiments argue against a per-
oxisomal contribution to the reduced kidney size in Scp2 mor-
phants, since the stunted proximal tubular growth by Mevinolin
was independent of any detectable peroxisomal defects. Whole
mount in situ hybridizations of Mevinolin-treated embryos did not
show any changes in the expression of Pmp70 or Catalase (Fig. 5H-I').
Together these data indicate that interfering with lipid rafts by
inhibiting cholesterol synthesis (i.e. Mevinolin) or by knocking
down scp2 results in similar proximal tubular growth phenotypes.
Fig. 4. Scp2 and Lipid Rafts. (A–D') Immunoﬂuorescence analysis of uninjected controls and scp2-MO1þ2-injected embryos at stage 40 using Caveolin-1 (A–B') or Rab5
(C–D') antibodies with the gray-scale image showing Caveolin-1 or Rab5 staining alone and the color panels showing merged images. ECL was used to identify proximal
tubules (green), DAPI (blue) to visualize nuclei. (E) Quantiﬁcation of the number of Caveolin-1-positive foci identiﬁed in (A,B). The number of embryos analyzed is
indicated in the individual bars. Data were analyzed by Student's t-Test and the three asterisks indicate a signiﬁcance of po0.001. (F) Metabolomics analysis of uninjected
and scp2-MO1þ2-injected embryos at stage 38 showing Box-and-Whisker Plots for cholesterol, 7-dehydrocholesterol and palmitoyl sphingomyelin.
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Discussion
Lipid rafts are instrumental in compartmentalizing diverse
cellular processes such as signaling, endocytosis and mechanosen-
sing in the cellular plasma membrane (Simons and Ikonen, 1997;
Hooper, 1999; Vogel and Sheetz, 2006; Parton and Simons, 2007).
The importance for lipid rafts has been well established in cell
culture. Surprisingly, their in vivo relevance is generally accepted,
but thorough analyses are rare. This, to a large part, is due to the
fact that many techniques used to study rafts in vitro (e.g. density
gradients) are not applicable to the mixed population of different
cell types found in living organisms. Most in vivo data are based on
removing or lowering the core lipid components of rafts such as
cholesterol and sphingolipids using chemicals (Hooper, 1999).
Unfortunately, the effect of these compounds is obviously not
restricted to the lipid microdomains, but interferes with all cell
membranes and the interpretation of the results can therefore be
difﬁcult. Thus, interfering with proteins contributing to lipid rafts
formation or maintenance – such as the one performed in this
study – has emerged as the most promising alternative (Drab et al.,
2001; Razani et al., 2001; Zhao et al., 2002; Ludwig et al., 2010).
Cell culture studies have implicated scp2 as a lipid raft
modulator (Starodub et al., 2000; Milis et al., 2006; Atshaves et
al., 2007a). In this study we now demonstrate that these ﬁndings
are in vivo relevant and scp2 is an important protein for lipid raft
composition and function. Moreover, it is independent of
other membrane-associated pathways such as Clathrin-mediated
endocytosis. This interpretation is based on the following three
Fig. 5. Proximal Tubule Phenotype upon Inhibition of Cholesterol Synthesis. (A–B') Immunoﬂuorescence analysis of untreated controls and embryos treated with 125 μM
Mevinolin at stage 40 using anti-Caveolin-1 (red) antibody and ECL (green) with the gray-scale image showing Caveolin-1 staining alone and the color panels showing
merged images. DAPI (blue) was used to visualize nuclei. (C) Quantiﬁcation of the number of Caveolin-1-positive foci identiﬁed in (A,B). The number of embryos analyzed is
indicated in the individual bars. Data were analyzed by Student's t-Test and asterisk represent a signiﬁcance of po0.05. (D) Bar diagram of the number of proximal tubular
cells in untreated controls and Mevinolin-treated embryos at stages 40. The number of embryos analyzed is indicated in the individual bars. Data were analyzed by Student's
t-Test and the three asterisks indicate a signiﬁcance of po0.001. (E–I') Untreated controls and Mevinolin-treated embryos were processed for 3G8 and 4A6
immunohistochemistry at stage 40 (E–F') or whole mount in situ hybridization with β1-Na/K ATPase (G,G'), Pmp70 (H,H') and Catalase (I,I') at stage 39. (J,J') Model for the
role of lipid rafts in proximal tubule elongation in the wild-type situation (J) or in the absence of scp2 or upon treatment with Mevinolin (J'). See discussion for details.
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facts: (1) Xenopus embryos lacking scp2 protein show a reduced
number of Caveolin-1 positive lipid rafts, but no defects in the
classical endosomal compartment (Fig. 4A-E). (2) The overall levels
of cholesterol and palmitoyl sphingomyelin are not altered in scp2
morphants (Fig. 4F). (3) The pronephric kidney phenotype of
embryos lacking scp2 mimics the one of embryos treated with the
cholesterol synthesis blocker Mevinolin (compare Figs. 3, 4 and 5).
The instrumental role of scp2 as a lipid carrier for raft forma-
tion is also underscored by gain-of-function analyses. Embryos
microinjected with a variety of scp2 mRNA or DNA exhibited poor
to no survival until late stages of development. Thus, we did not
examine the effect of ectopic scp2 expression on the pronephric
kidney. However, the mRNA overexpression phenotype was quite
revealing. Animal cap cells from injected embryos displayed
weaker cell-to-cell contacts and dropped out of the ectodermal
cell layer into the blastocoel and underwent apoptosis as early as
blastula stage (data not shown). Even though we did not thor-
oughly test it, we hypothesized that this phenotype was caused by
changes in the cell membrane lipid composition, which thereby
modiﬁed the biophysical characteristics of the cells (e.g. surface
tension or membrane ﬂuidity).
One puzzling aspect of our study is that the scp2 knockdown
phenotype in Xenopus is more severe than the one in the mutant
mice (Seedorf et al., 1998; Atshaves et al., 2007b). Scp2-deﬁcient
mice display defects in lipid metabolism, but are viable and do not
exhibit developmental deﬁciencies. However, these mice have not
been studied in respect to lipid raft biology and the relatively weak
phenotype may be explained by compensation by other lipid
carriers. The best candidate is Caveolin-1, which like scp2 trans-
ports cholesterol and other lipids from the intracellular sites to the
plasma membrane and is involved in lipid raft formation (Smart
et al., 1996). Importantly and in line with the possibility of redun-
dancy, even Caveolin-1 mutant mice only show a relatively mild
phenotype considering its presumed central role in lipid raft
biogenesis and function (Drab et al., 2001; Razani et al., 2001;
Zhao et al., 2002).
Finally, the pronephric phenotype observed by interfering with
lipid rafts (i.e. shortened proximal tubules) is highly reminiscent to
two recent reports by our group (Zhang et al., 2013; Romaker et al.,
2014). Indeed, we believe that all three phenotypes are intercon-
nected. Zhang et al. (2013) described that changes in cAMP levels
cause increased endocytosis and decreased exocytosis, while
Romaker et al. (2014) identiﬁed the role of Insulin and Igf2 in
promoting proximal tubule growth. Insulin receptor signaling is
well characterized (Pike, 2005; Taniguchi et al., 2006). One
particular feature is that the localization of the Insulin/Igf recep-
tors to rafts is essential for active signaling (Gustavsson et al.,
1999; Vainio et al., 2002; Karlsson et al., 2004). The lipid rafts are
thought to potentiate the signaling efﬁciency by local clustering of
the receptors and downstream signaling components (Pike, 2005).
Thus, the simplest scenario for the data presented here (Fig. 5J,J') is
that Insulin/Igf2 trigger proliferation by binding to Insulin/Igf
receptors clustered in lipid rafts. In the absence of scp2 and the
reduction of lipid raft numbers, this process is impaired causing
reduced proximal tubular growth. One alternative, not necessarily
exclusive hypothesis is that the secretion of Insulin/Igf2 from the
proximal tubules is reduced. Indeed, lipid rafts are the place of
intense vesicle trafﬁcking and exocytosis (Salaun et al., 2004). This
would also be in line with the data presented in Zhang et al.
(2013), which demonstrate that inhibition of secretion by Golgi-
cide A causes shortened proximal tubules. In the future, it will be
important to experimentally address these two possibilities by
directly assaying ligand secretion and receptor activation using e.g.
GFP-tagged versions of Insulin or Igf2. But besides these open
questions, it is very intriguing that three quite different experi-
mental approaches converged on a single process.
In summary, this study exempliﬁes the advantages of Xenopus
as a model to bridge cell culture and in vivo experiments. The
accessibility of the developing frog embryo to chemical com-
pounds (Adams and Levin, 2006; Kalin et al., 2009) and micro-
injections allowed us to directly compare a classical cell biological
approach with a modern loss-of-function study. This type of
approach will undoubtedly allow us to translate observations seen
in cell culture to a relevant in vivo situation and better understand
the basic molecular mechanisms involving lipid rafts.
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